Trial Profile
A Phase 1 Randomized, Double-Blind. Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type 1 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs TOL 3021 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 27 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 26 Oct 2010 Planned End Date changed from 1 Dec 2008 to 1 Oct 2011 as reported by ClinicalTrials.gov.